Figure 2. Illustration of disulfiram (DSF), sunitinib and disulfiram-sunitinib co-exposure induced effects on prostate cell viability.
Relative cell viability results in A) VCaP and B) PC-3 prostate cancer cells as well as in non-malignant C) RWPE-1 and D) EP156T cells. Asterisks indicate the statistical significance: *, P<0.05; **, P<0.01; and ***, P<0.005.